Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01099 SINOPHARM
RTNominal unchange19.780 0.000 (0.000%)
Result Announcements

24/04/2020 11:02

Sinopharm (01099) unit 1Q net down 19% to RMB231.97m

[ET Net News Agency, 24 April 2020] Sinopharm Group Co. Ltd. (01099) announced the
results of its subsidiary China National Medicines Corporation Ltd.
The net profit attributable to shareholders of the listed company was RMB231.97 million
for the three months ended 31 March 2020, a year-on-year decrease of 19.02%. The earnings
per share were RMB0.3075.
The operating income was RMB8.21 billion, a year-on-year decrease of 18.3%. (RC)

Back to Result Announcements

Remark: Real time quote last updated: 19/04/2024 08:09
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.